Financing and Public Support
Wallonia offers one of Europe’s most complete and collaborative financing environments for life sciences. Its ecosystem brings together public investors, private funds, international co-investors, and tailored support mechanisms, ensuring that life sciences companies can access the right capital, expertise, and support at every stage of their growth.
/--/uploads/sites/4/2026/01/financing-WE.jpg)
Strong Public Anchors
Wallonia’s public investors have co-financed over 130 companies across the region, providing flexible investment tickets from €0.5 million to €10 million, with room to go higher through syndication.
Together with SFPIM – the Belgian Federal Holding and Investment Company -, these patient, catalytic investors back companies from seed to Series C+, co-investing alongside Belgian and international VCs, while offering long-term capital, strategic guidance, and sector expertise.”
/--/uploads/sites/4/2026/01/growth.jpg)
Grants and Support Tools
Innovators can benefit from 50 to 80% public R&D funding coverage through the Walloon Administration for Research, in the form of grants and recoverable advances..
Fiscal measures include tax incentives and payroll tax exemptions for researchers and R&D teams.
BioWin, Wallonia’s Health Cluster, provides tailored support for innovation, partnership development, and access to collaborative R&D projects.
The Wallonia Export & Investment Agency (AWEX) complements this ecosystem by supporting internationalization and global market expansion.”
